(EZM) WisdomTree U.S. MidCap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717W5702 • Small Value

EZM: Stocks, MidCap, US, Earnings

The WisdomTree U.S. MidCap Earnings Fund (EZM) is an exchange-traded fund (ETF) designed to track the performance of the WisdomTree U.S. MidCap Earnings Index. Under normal market conditions, the fund allocates at least 95% of its total assets to securities that are either components of the index or exhibit economic characteristics closely aligned with those components. This approach ensures the fund stays closely tied to the indexs composition and investment strategy.

The index itself is fundamentally weighted, focusing on mid-capitalization companies within the U.S. stock market that generate earnings. By targeting earnings-generating firms, the fund seeks to provide exposure to companies with established operations and revenue streams. Mid-capitalization companies often represent a sweet spot in the market, offering the growth potential of smaller firms while maintaining the stability associated with larger enterprises. The fund is classified as non-diversified, meaning it can concentrate its holdings in a smaller number of securities, which may increase its potential for higher returns but also raises the risk profile compared to diversified funds.

With total assets under management (AUM) of $798.42 million, the fund is part of the Small Value ETF category. It trades on the NYSE ARCA under the ticker symbol EZM. For more information, investors can visit the funds website at http://www.wisdomtree.com.

Looking ahead, the WisdomTree U.S. MidCap Earnings Fund is well-positioned to capitalize on the evolving dynamics of the U.S. mid-cap market. As earnings growth remains a critical driver of equity valuations, the funds focus on companies with demonstrated profitability could provide a stable foundation in varying market conditions. Additionally, as interest rates continue to shape investor preferences, the funds exposure to mid-cap companies may offer a balance between growth and income potential. Over the long term, the funds fundamentally weighted approach could benefit from a rebalancing effect, as it adjusts to changes in the earnings landscape of its constituents.

Additional Sources for EZM ETF

EZM ETF Overview

Market Cap in USD 716m
Category Small Value
TER 0.38%
IPO / Inception 2007-02-23

EZM ETF Ratings

Growth Rating 67.8
Fundamental -
Dividend Rating 40.1
Rel. Strength -9.41
Analysts -
Fair Price Momentum 53.02 USD
Fair Price DCF -

EZM Dividends

Dividend Yield 12m 1.30%
Yield on Cost 5y 2.70%
Annual Growth 5y 0.92%
Payout Consistency 92.4%

EZM Growth Ratios

Growth Correlation 3m -91.1%
Growth Correlation 12m 34.6%
Growth Correlation 5y 79.8%
CAGR 5y 15.12%
CAGR/Max DD 5y 0.64
Sharpe Ratio 12m -0.43
Alpha -9.51
Beta 0.900
Volatility 37.44%
Current Volume 16.2k
Average Volume 20d 26.1k
What is the price of EZM stocks?
As of April 29, 2025, the stock is trading at USD 57.26 with a total of 16,230 shares traded.
Over the past week, the price has changed by +6.08%, over one month by -3.46%, over three months by -11.32% and over the past year by -0.92%.
Is WisdomTree U.S. MidCap a good stock to buy?
Yes. Based on ValueRay Analyses, WisdomTree U.S. MidCap (NYSE ARCA:EZM) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.79 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EZM as of April 2025 is 53.02. This means that EZM is currently overvalued and has a potential downside of -7.4%.
Is EZM a buy, sell or hold?
WisdomTree U.S. MidCap has no consensus analysts rating.
What are the forecast for EZM stock price target?
According to ValueRays Forecast Model, EZM WisdomTree U.S. MidCap will be worth about 59.5 in April 2026. The stock is currently trading at 57.26. This means that the stock has a potential upside of +3.89%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 59.5 3.9%